Home
Scholarly Works
A phase 1/2 study of ipilimumab in women with...
Conference

A phase 1/2 study of ipilimumab in women with metastatic or recurrent HPV-related cervical carcinoma: A study of the Princess Margaret and Chicago N01 Consortia.

Authors

Lheureux S; Butler MO; Fleming GF; Hirte HW; Cristea MC; Ghatage P; Martin LP; Mackay H; Dhani NC; Wilson M

Volume

32

Pagination

pp. tps5631-tps5631

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2014

DOI

10.1200/jco.2014.32.15_suppl.tps5631

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team